CLIN EXP METASTAS 润色咨询

CLINICAL & EXPERIMENTAL METASTASIS

出版年份:1983 年文章数:975 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2021-12-28 rayms

    通讯作者最多有多少个?同第一作者最多有多少个?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    作者可以写中文名么?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2017-07-18 chenyuming

    3分边缘,希望能维持稳定,略有上升也不错。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2012-12-17 CHANGSCI

    荷兰刊物
    主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2012-07-10 匿名用户

    4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2012-03-28 匿名用户

    依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2012-03-16 匿名用户

    2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2011-07-07 lovelace

    审稿速度:12.0 | 投稿命中率:25.0
    经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2011-03-01 匿名用户

    有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。
    谁解其中味?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1088833, encodeId=48be1088833cb, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088834, encodeId=2c3510888340e, content=作者可以写中文名么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539335, encodeId=884f5393351c, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492975, encodeId=0a8c4929e5df, content=荷兰刊物 <br> 主要发表恶性肿瘤转移性疾病的临床与实验研究论文,涉及病灶的成因及其相关的生物化学、细胞生物学、病理学、分子遗传学、免疫学等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b38e74299, createdName=CHANGSCI, createdTime=Mon Dec 17 22:34:00 CST 2012, time=2012-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489556, encodeId=58164895564d, content=4月16日接到大修意见,感觉还挺中肯,6月24日修回,6月26日再次送审,现在还是under review中,感觉不是很好,可能要挂啊,等待真是痛苦啊!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jul 10 12:42:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487572, encodeId=82bc48e5722f, content=依然没有回复,着急啊,接受就算了,要是拒稿的话... ...来个痛快的啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=505, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 28 11:04:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487308, encodeId=38c848e308d3, content=2月11日上传的文章,中间因为格式改过2次,3月2日变成 Reviewers Assigned,3月14日写了封催稿信,回信挺友好,说有位审稿人已经回复,还在等其余的审稿人的答复,怎么这么慢啊,焦急等待中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 16 08:47:00 CST 2012, time=2012-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483363, encodeId=e83c48336359, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:我的文章终于接收了,我是2010年11月24日投稿,2011年4月15日接到大修意见,6月21日修回,7月7日accepted,我苦苦等了7月,终于有了好结果。以后多努力!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58aa26767, createdName=lovelace, createdTime=Thu Jul 07 19:00:00 CST 2011, time=2011-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474000, encodeId=d7144e40000d, content=有一种等待叫做无赖,有一种狂妄叫做无知,有一种侮辱叫做无视,有一种待人叫忽悠,有一种态度叫放纵,有一种愤恨叫无声。 <br> 谁解其中味?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 01 08:18:00 CST 2011, time=2011-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473853, encodeId=08574e385332, content=已经3个月了,依旧没有结果,着急,为啥会这样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=lovelace, createdTime=Tue Feb 22 19:58:00 CST 2011, time=2011-02-22, status=1, ipAttribution=)]
    2011-02-22 lovelace

    已经3个月了,依旧没有结果,着急,为啥会这样?

    0

共15条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分